Please login to the form below
vilaprisan
This page shows the latest vilaprisan news and features for those working in and with pharma, biotech and healthcare.
Bayer moves vilaprisan into phase III trials for uterine fibroids
Bayer moves vilaprisan into phase III trials for uterine fibroids. ASTEROID study will investigate safety and efficacy of the novel drug. ... Bayer is beginning late-stage trials of vilaprisan, its novel oral, selective progesterone receptor modulator
Latest news
-
Xarelto and Eylea continue to dominate Bayer's pharma sales
They include five candidates in phase III trials: copanlisib for non-Hodgkin lymphoma, ODM-201 for hormone-sensitive prostate cancer, finerenone for diabetic kidney disease, vilaprisan for uterine fibroids and endriametosis
-
Allergan plans to file oral uterine fibroid drug in US by year-end
Other companies working on new therapies for uterine fibroids include Bayer, which has a candidate called vilaprisan in mid-stage clinical development.
-
Allergan on course to file uterine fibroid drug next year
Other companies working on new therapies for uterine fibroids include Bayer, which has a candidate called vilaprisan in mid-stage clinical development.
-
Bayer puts research at heart of business growth
The other two drugs touted to advance to phase III are copanlisib for non-Hodgkin's lymphoma and vilaprisan to treat symptomatic uterine fibroids – begin tumours that form in the uterus. “
More from news
Approximately 1 fully matching, plus 4 partially matching documents found.
Featured jobs
- Scientific Director / Editorial Team Leader
-
Great salary and benefits
- Account Manager, Healthcare Public Affairs
-
£32, 000 – £40, 000 benefits
- Programme Director, Healthcare PR, Highly competitive package
-
Highly Competitive package
- Events Manager – Med Comms – Surrey
-
Salary TBC
- Senior Account Managers - Oxfordshire
-
Attractive salary and benefits package offered
-
Senior Medical Writer
-
Great salary and benefits
- Senior Account Executive, London, Medical Communications
-
Excellent package
-
Associate Medical Director
-
Highly Competitive
- Director, Market Access / HEOR - North-West
-
Negotiable
-
Medical/ Scientific Director
-
Salary TBC
-
New Business Director - PR
-
Competitive Salary and benefits
-
Associate Director
-
£75, 000-90, 000
-
Senior Account Manager
-
Negotiable
- Senior Medical Writer (Remote Working)
-
Competitive Salary Offered
-
Account Director
-
Excellent benefits
- Digital Manager, London – Healthcare Brandcomms, Medcomms, PR
-
Excellent package
Subscribe to our email news alerts
- Confocal Microscope Market to Witness Notable Revenue Growth in North America Owing to Increasing Spending on R&D Initiatives in the Region
- Confocal Microscope Market to Witness Notable Revenue Growth in North America Owing to Increasing Spending on R&D Initiatives in the Region
- Carpal Tunnel Release Systems Market to reach a market valuation worth US$ 839.1 Mn by the end of 2028
- Digital Radiography Detectors Market to reach a valuation of US$ 2,713.7 Mn by 2026, exhibiting a promising 6.1% CAGR during 2018-2026.
- Analgesics Market is anticipated to reach a whopping US$ 79 Bn by 2028 end
- High Cost Factor and Health Risks Arising from Surgical Procedures Restraining Revenues in the Hearing Implant Market
PMHub
Publicis Resolute
Publicis Life Brands Resolute provides real-life practical solutions to your issues, without fuss or fluff. We are an experienced team...
Latest intelligence
- Innovation in merger control and the impact on the pharmaceutical sector
- Is focusing on pipeline products enough to assess regulatory risks?...
- Nudge-nudge, think-think
- Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...
- Quality in Care Diabetes 2018: the best in innovative diabetes care
- Awards highlight new evidence-based approaches to improving care...
Quick links
Infographics
